Thymosin α1 Augments CD8⁺ T-Cell Activation and Reverses Exhaustion In Vitro
- 1Amity Institute of Biotechnology, Amity University Maharashtra, Mumbai-Pune Expressway, Bhatan, Post Somathne, Panvel, India.
- 2Amity University Maharashtra, Mumbai-Pune Expressway, Bhatan, Post Somathne, Panvel, India.
- 3BioRadius Therapeutic Research Pvt. Ltd., Pune, Maharashtra, India.
Abstract
Background:: Thymosin alpha 1 (Tα1) is a thymic peptide hormone secreted by the thymus gland with known immunomodulatory properties, yet its specific effects on human CD8⁺ T-cell function remain incompletely understood. This study investigates the influence of Tα1 on CD8⁺ T-cell proliferation, activation, cytokine secretion, and exhaustion status in vitro.
Methods:: Human CD8⁺ T-cells were cultured and treated under four conditions: untreated (negative control), CD3/CD28 stimulation (positive control), Tα1 treatment, and combined CD3/CD28 + Tα1 stimulation. Proliferation was measured using carboxyfluorescein succinimidyl ester (CFSE)-based flow cytometry. Surface expression of activation markers (CD69, CD25, HLA-DR) and exhaustion markers (PD-1, TIM-3, LAG-3) was analyzed by flow cytometry. Cytokine secretion (IL-2, IFN-γ, TNF-α, IL-10) was assessed using a multiplex bead-based assay. T-cell exhaustion was induced by repeated CD3/CD28 stimulation before Tα1 treatment.
Results:: Tα1 alone moderately increased proliferation and activation of CD8⁺ T-cells, while the combination of Tα1 and CD3/CD28 significantly enhanced the proliferation index and surface expression of CD69, CD25, and HLA-DR compared with individual treatments. Cytokine secretion of IL-2, IFN-γ, TNF-α, and IL-10 was elevated in the combination group, indicating enhanced effector function. In the exhaustion model, CD8⁺ T-cells exhibited overexpression of PD-1, TIM-3, and LAG-3, which was significantly reduced upon Tα1 treatment, suggesting a partial reversal of the exhausted phenotype.
Conclusion:: Tα1 promotes functional activation of CD8⁺ T-cells and mitigates exhaustion marker expression following chronic stimulation. These findings suggest that Tα1 could potentially serve as a supportive agent in T-cell-based immunotherapies by enhancing activation and partially reversing exhaustion in vitro, warranting further in vivo validation.
Related
- CD47 blockade augments anti-GD2 driven phagocytosis in vitro but fails to improve in vivo efficacy in immunocompetent, chemoresistant neuroblastoma preclinical models
- p53 activation via pharmacologic MDM2 inhibition constrains exhaustion and enhances antitumor function of human CD8+ T cells
- AN IMPAIRED DNAM-1/NKP80 NK-CELL ACTIVATION AND T-CELL EXHAUSTION PROFILE AT DIAGNOSIS PRECEDE SUBOPTIMAL EARLY MOLECULAR RESPONSE IN CML
- Comparative Transcriptomic Profiling of Diabetic Wound Responses to Recombinant Periplaneta americana Thymosin Isoforms in Male ob/ob Mice
- The Orai3 channel and AHNAK2 scaffold protein promote the activation of primary human muscle stem cells in vitro
BibTeX
@article{mishra2026thymosin,
title = {{Thymosin α1 Augments CD8⁺ T-Cell Activation and Reverses Exhaustion In Vitro}},
author = {Smriti Mishra and Gaurang Telang and Anurag Sureshbabu and Samruddhi Kulkarni and Sagar Barage and A.W. Santosh Kumar and Rajshri Singh},
journal = {Asian Pacific Journal of Cancer Prevention : APJCP},
year = {2026},
month = jun,
doi = {10.31557/apjcp.2026.27.6.2089},
url = {https://doi.org/10.31557/apjcp.2026.27.6.2089},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Thymosin α1 Augments CD8⁺ T-Cell Activation and Reverses Exhaustion In Vitro
AU - Smriti Mishra
AU - Gaurang Telang
AU - Anurag Sureshbabu
AU - Samruddhi Kulkarni
AU - Sagar Barage
AU - A.W. Santosh Kumar
AU - Rajshri Singh
PY - 2026
DA - 2026/06/19
JO - Asian Pacific Journal of Cancer Prevention : APJCP
DO - 10.31557/apjcp.2026.27.6.2089
UR - https://doi.org/10.31557/apjcp.2026.27.6.2089
AB - Background:: Thymosin alpha 1 (Tα1) is a thymic peptide hormone secreted by the thymus gland with known immunomodulatory properties, yet its specific effects on human CD8⁺ T-cell function remain incompletely understood. This study investigates the influence of Tα1 on CD8⁺ T-cell proliferation, activation, cytokine secretion, and exhaustion status in vitro. Methods:: Human CD8⁺ T-cells were cultured and treated under four conditions: untreated (negative control), CD3/CD28 stimulation (positive control), Tα1 treatment, and combined CD3/CD28 + Tα1 stimulation. Proliferation was measured using carboxyfluorescein succinimidyl ester (CFSE)-based flow cytometry. Surface expression of activation markers (CD69, CD25, HLA-DR) and exhaustion markers (PD-1, TIM-3, LAG-3) was analyzed by flow cytometry. Cytokine secretion (IL-2, IFN-γ, TNF-α, IL-10) was assessed using a multiplex bead-based assay. T-cell exhaustion was induced by repeated CD3/CD28 stimulation before Tα1 treatment. Results:: Tα1 alone moderately increased proliferation and activation of CD8⁺ T-cells, while the combination of Tα1 and CD3/CD28 significantly enhanced the proliferation index and surface expression of CD69, CD25, and HLA-DR compared with individual treatments. Cytokine secretion of IL-2, IFN-γ, TNF-α, and IL-10 was elevated in the combination group, indicating enhanced effector function. In the exhaustion model, CD8⁺ T-cells exhibited overexpression of PD-1, TIM-3, and LAG-3, which was significantly reduced upon Tα1 treatment, suggesting a partial reversal of the exhausted phenotype. Conclusion:: Tα1 promotes functional activation of CD8⁺ T-cells and mitigates exhaustion marker expression following chronic stimulation. These findings suggest that Tα1 could potentially serve as a supportive agent in T-cell-based immunotherapies by enhancing activation and partially reversing exhaustion in vitro, warranting further in vivo validation.
SN - 1513-7368
SN - 2476-762X
ER -